Kalshi, Polymarket trading volumes on some products raises questions amid massive growth

Kalshi and Polymarket face scrutiny over potentially inflated trading volumes, with Kalshi's bitcoin and ether perpetual-futures volumes running about 42x and 66x open interest, respectively. On Polymarket International, low-probability contracts showed anomalously high activity, including nearly $56 million traded on an Ethiopian prime-minister candidate whose odds remained below 3%, versus roughly $170,000 for the eventual winner. Both platforms deny wash trading, but the CFTC is reportedly examining Kalshi ether-perpetual trades and questions over volume quality could pressure private-market valuations reportedly above $20 billion for Polymarket and $40 billion for Kalshi ahead of potential public listings.

Analysis

The investable implication is primarily a relative-quality premium for incumbent regulated venues, not a near-term earnings event for CME. If incentive-driven turnover becomes a regulatory focus, the cost of surveillance, market-maker oversight, and fee-program compliance rises materially for newer exchanges; that weakens their ability to use headline volume to support private-market multiples. CME benefits at the margin because its clearing, surveillance, and open-interest-based liquidity metrics are independently legible to institutions, though prediction-market activity remains too small to move CME fundamentals.

The more consequential risk is a CFTC precedent that treats excessive rebate-driven churn or misleading liquidity presentation as a market-structure violation even absent proven wash trading. Over the next 1-3 months, any formal inquiry, enforcement action, or mandated redesign of incentive programs could impair the growth narrative needed by private prediction-market platforms ahead of prospective listings. A softer outcome—no action beyond routine monitoring—would leave the volume debate largely reputational and could permit private valuations to remain detached from durable fee revenue.

Consensus may be too focused on whether activity is technically wash trading. The relevant valuation question is whether volume converts into net revenue, retained funded accounts, open interest, and low acquisition costs after incentives are removed. High turnover relative to committed capital can be economically rational during a launch, but it is not evidence of a defensible exchange network; a post-incentive decline in volume without a corresponding improvement in open interest would expose weak underlying demand. This is a watch item rather than a standalone CME trade absent evidence that regulated event contracts are taking meaningful institutional flow from CME products.

Key Decisions for Investors

• Maintain CME as a relative-quality long versus prospective private prediction-market IPO exposure; use any broad regulatory selloff in exchange operators to add, with a 6-18 month horizon. The thesis is franchise durability and clearing economics, not direct revenue capture from this episode.
• Do not initiate a directional CME position solely on this news. Require evidence of either sustained migration of hedging/event volume to CME-adjacent products or a regulatory action that raises competitors' compliance costs before underwriting incremental upside.
• Create an alert for a formal CFTC enforcement action, subpoena disclosure, or mandated change to fee/rebate programs at regulated prediction venues over the next 90 days. Such an event would strengthen the relative long-CME thesis but could also create a short-term sympathy drawdown across exchange equities.
• For any future prediction-market IPO, underwrite valuation against fee revenue, average funded balances, open interest, incentive expense, and post-rebate retention—not reported notional volume. Avoid participation if volume decelerates sharply when incentives expire or if open interest fails to scale with turnover.